In order for periodontal regeneration to occur, progenitor cells must migrate to the denuded root surface, attach to it, proliferate and mature into an organized and functional fibrous attachment apparatus. Significant advances have been made during the last decade in understanding the factors controlling the migration, attachment and proliferation of cells. A group of naturally occurring molecules known as polypeptide growth factors in conjunction with certain matrix proteins, are key regulators of these biological events. Of these, the fibroblast growth factors (FGFs) appear to have an important role in periodontal wound healing. The purpose of this review is to summarize current information on these growth factors with emphasis on their potential implications in periodontal wound healing and regeneration.
INTRODUCTION
Fibroblast growth factors (FGFs) are members of the heparin binding growth factor family and are polypeptides that are potent mitogens and chemoattractants for endothelial cells as well as for a variety of mesenchymal cells, including fibroblasts, osteoblasts, chondrocytes, smooth muscle cells, skeletal myoblasts and for cells of neuro-ectodermal origin. FGF have not only growth-promoting effects on most fibroblastic cell types, but it also stimulates angiogenesis, neovascularization, wound healing and cell migration. 
FORM AND RECEPTOR (Figure 1)
FGFs are a family of 9 heparin-binding polypeptides, aFGF (FGF-1), bFGF (FGF-2), int-2 (FGF-3), Kaposi sarcoma FGF (K-FGF; also known as the product of hst-1 oncogene: FGF-4), FGF-5, FGF-6, keratinocyte growth factor (KGF: FGF-7), androgen-induced growth factor (FGF-8) and FGF-9. 4 They all have similar activities; mitogenicity for cells of mesodermal and neuro-ectodermal origin and potent angiogenic activity in vivo. 3 The two most studied members of this family are acid FGF (a-FGF or FGF-1) and basic FGF (b-FGF or FGF-2). growth factor, retinal-derived growth factor and astroglial growth factor. FGF-2 has similar properties and is related to eye-derived growth factor I, heparin binding growth factor β, chondrosarcoma-derived growth factor, hepatoma-derived growth factor and astroglial factor-2. 
SOURCES
Both FGF-1 and FGF-2 were initially isolated from neural tissue but have been subsequently found in numerous other tissues. 5 FGF-2 has been shown to be produced in the brain, pituitary gland, kidney, corpus luteum, and adrenal gland. FGFs are multifunctional regulatory peptides with a great impact on studies of tumorigenesis, cardiovascular disease, repair of tissue injury, neurobiology and embryonic development. 34 They are responsible for critical functions in wound healing, tissue repair, angiogenesis, and homeostatic regulation.
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New blood vessel formation (Angiogenesis):
FGF-2, in particular has the ability to induce all steps necessary for new blood vessel formation both in vivo and in vitro. 6 FGF-1 stimulates endothelial cell proliferation. 9 FGF-2 actively regulates the production of type I collagen and laminin by PDL cells. Laminin is one of the most important biological substances which participate in angiogenesis. On the other hand, FGF-2 has a most effective potential activity for angiogenesis. It has been observed in animal studies that where FGF-2 had been applied at the early phase of the wound healing process, many newly formed capillaries were observed around that area. This suggests that the production of laminin by PDL cells which is a reaction for the stimulation of FGF-2 may be helpful to angiogenesis in periodontal tissues. Development: The FGFs are believed to act as competence growth factors. This implies that FGF stimulates resting cells in GO to enter the cell cycle in G1. Once these resting cells enter the cell cycle, progression growth factors are needed to stimulate their transit through GI into the S phase or synthetic phase. Therefore, FGFs initiate a cascade of cellular events but require synergistic action with progression growth factors to maximize DNA synthesis and cell growth. 1 FGFs play a role in skeletal muscle development and in lung maturation. For example, FGF-6 and its receptor induce myoblast proliferation and suppress myocyte differentiation, providing a supply of proliferating myocytes. FGF-2 is also thought to be involved in the generation of angioblasts during embryogenesis. FGF-1 and FGF-2 are involved in the specification of the liver from endodermal cells.
Hematopoiesis:
FGFs have been implicated in two aspects of hematopoesis-development of specific lineages of blood cells and the development of bone marrow stroma. stimulates periosteum derived cells in early stages of bone healing. 8 Some of these effects may be mediated through increases in transforming growth factor-β production. 2 Systemic administration of FGF stimulates bonefracture healing, induces new bone formation, and increases bone mass, suggesting that there may be a therapeutic role for FGF in the treatment of osteopenia. Also, rapid bone healing has been induced in animal models by FGF-2.
Role in periodontium:
The stimulatory effects of FGFs on neovascularization, in addition to the chemotactic and mitogenic effects on mesodermal cells, in particular to fibroblasts and osteoblasts, suggest an important role of these proteins in periodontal wound healing and regeneration. 1 Studies on the effects of FGF on individual cell types have shown that it can stimulate endothelial cell and periodontal ligament cell migration and proliferation.
2 FGF-2 is widely distributed in nearly all periodontal tissues, including gingiva, periodontal ligament and bone. FGF-2 has been reported to stimulate periodontal ligament and endothelial cell migration; increases DNA synthesis and inhibits the alkaline phosphatase production of periodontal ligament cells. 9 FGF-2 enhances the proliferation of the PDL cells in a dose-dependent manner and the response reaches plateau at the concentration of 10ng/ml. In addition, the proliferative response is decreased when the concentration on FGF-2 is over 100ng/ml. In contrast, alkaline phosphatase activities by PDL cells are completely inhibited at concentrations more than 10ng/ml. Though FGF-2 induces proliferation but it inhibits cytodifferentiation of PDL cells into osteogenic cells. It also abrogated the synthesis of type I collagen, which is one of the most common extracellular matrices in the periodontium and is essential for calcified nodule formation. 4 FGF-2 may stimulate the release of proteoglycans via the increase in MMP-3 production. 10 Thus they stimulate proliferation of most of the major cell types involved in wound healing both in vitro and in vivo, including vascular endothelial cells, fibroblasts, keratinocytes, chondrocytes and myoblasts. 3 In-vivo studies have demonstrated that a topical application of exogenous FGF-2 enhances the healing process of duodenal ulcers, chronic pressure sores, and bone fractures. Furthermore, recently it has been reported that local application of exogenous FGF-2 enhanced periodontal regeneration following experimental alveolar bone defects in beagle dogs and primates. In those experiments, it was noteworthy that no epithelial downgrowth, ankylosis, or root resorption was observed in the FGF-2 applied sites. This strongly suggests that FGF-2 plays an important role in the process of periodontal tissue regeneration, and it may also influence or regulate the functions of gingival epithelial cells, which are important components of periodontal tissue.
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CONCLUSION
Fibroblast growth factors are a group of naturally occurring heparin-binding proteins that are potent mitogens and chemoattractants for various cells. These properties have led to the proposal that they play important roles in wound healing and regeneration of tissues. It is probable that, in the future, periodontal therapy will include root surface demineralization to expose the collagenous root matrix and topical application of a combination of polypeptide growth factors including FBFs in a slowrelease biodegradable device to promote the migration, proliferation and maturation of specific progenitor cell populations capable of regenerating the periodontium.
